Compugen (NASDAQ:CGEN) Upgraded by StockNews.com to Buy
StockNews.com upgraded shares of Compugen (NASDAQ:CGEN – Free Report) from a hold rating to a buy rating in a research report report published on Tuesday. Separately, Truist Financial cut their price target on Compugen from $5.00 to $4.00 and set a buy rating for the company in a research note on Tuesday. View Our Latest […]